The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Endogenous protease tissue-type plasminogen activator (tPA) has highly efficient fibrinolytic activity and its recombinant varian...
-
Another great intubation tip from Williamson County EMS. from EMS via xlomafota13 on Inoreader http://ift.tt/2sJ5JQz
-
Abstract Glutamate is the major excitatory neurotransmitter in the central nervous system. Beyond this function, glutamate also plays a ke...
-
Archives of Clinical Neuropsychology from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2eTSYdQ
-
Publication date: Available online 31 May 2016 Source: The Journal of Emergency Medicine Author(s): Drew Scribner, Robert Fraser Backgrou...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου